Isophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology)

精蛋白重组人胰岛素（合肥天麦生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIsophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2019/09/05
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHefei Tianmai Biotechnology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Tianmai Biotechnology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A